NRG
INSM icon

Nemes Rush Group’s Insmed INSM Stock Holding History

Nemes Rush Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213 Hold
2
– – ﹤0.01% 939
2026
Q1 		$327 Sell
2
-2
-50% -$307 ﹤0.01% 905
2025
Q4 		$696 Buy
+4
New +$730 ﹤0.01% 851
2025
Q3 		– Sell
-3
Closed -$302 – 710
2025
Q2 		$302 Buy
+3
New +$229 ﹤0.01% 702

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Nemes Rush Group's INSM Position: Q2 2026 in Review

Nemes Rush Group held its Insmed (INSM) position steady in Q2 2026 at 2 shares worth $213. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Nemes Rush Group first reported a position in INSM in Q2 2025 and has held it in 4 quarters since. The position peaked at $696 in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Nemes Rush Group held 2 shares of Insmed worth $213 as of Q2 2026.
  • Nemes Rush Group left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #939 holding.
  • Nemes Rush Group first reported a position in Insmed in Q2 2025 and has held it in 4 quarters since.
  • Nemes Rush Group's Insmed position peaked at $696 in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.